Beck Bode, LLC Dexcom Inc Transaction History

Beck Bode, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$84.79 - $104.74 $2.38 Million - $2.94 Million	-28,059 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $110,218 - $130,344	1,154 Added 4.29%	28,059 $11.6 Million
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $354,956 - $596,540	5,663 Added 26.66%	26,905 $10.9 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $478,664 - $757,510	10,016 Added 89.22%	21,242 $7.12 Million
Q4 2019 Jan 27, 2020	BUY	$36.62 - $57.29 $25,670 - $40,160	701 Added 6.66%	11,226 $2.46 Million
Q3 2019 Dec 02, 2019	BUY	$35.53 - $43.8 $373,953 - $460,994	10,525 New	10,525 $1.57 Million

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Bode, LLC with notifications on news.